Clinical Trials
- Digestive System
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
- Ages12 years - 75 years
- GenderBoth
- Digestive System
Operative Versus Non-Operative Management for Appendicitis With Abscess or Phlegmon
- Ages18 years and older
- GenderBoth
- Digestive System
Randomized, Multicenter Study of Combination Medications to Treat Active Crohn’s Disease (DUET-CD)
- Ages18 years - 65 years
- GenderBoth
- Digestive System
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)
- Ages60 years - 84 years
- GenderBoth
- Digestive System
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Digestive System
Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion 2018-07 Act Fast
- Ages40 years and older
- GenderBoth
- Digestive System
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
- Ages18 years - 75 years
- GenderBoth
- Digestive System
The OPTIMIZE Trial
- Ages18 years - 80 years
- GenderBoth
- Digestive System
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
- Ages18 years - 75 years
- GenderBoth
- Colorectal Cancer
A Phase I/Ib Global, Multicenter, Open-label Umbrella Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)